Clinical trial NCT02743507: The Impact of Bundled Payments on Quality and Cost of Care
Official title: The Impact of the Bundled Payments for Care Improvement Program on Quality and Costs of Care
Study type: OBSERVATIONAL
Overall status: ACTIVE_NOT_RECRUITING
Conditions: Osteoarthritis
Chronic Obstructive Pulmonary Disease
Pneumonia
Lead sponsor: University of Pennsylvania
Sponsor class: OTHER
First posted: 2016-04-19
Enrollment: 440
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_ONLY
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: The target population consists of a subset of provider organizations who participated in CMS's BPCI bundled payment program. From this group, the team will focus on provider organizations that participated in the largest model within the BPCI program (model 2) and accepted bundled payment for the ten most common MS-DRGs.

Brief summary: Bundled payment is a new payment reform that encourages health care providers to improve quality and contain costs of care. These arrangements are being rapidly expanded across the country, but evidence about their impact are lacking. This study will use Medicare claims data to evaluate the effect of participation in a large Medicare bundled payment program on the quality and costs of care for common medical and surgical conditions.

Detailed description: The overall objective is to examine the effects of the Bundled Payments for Care Improvement (BPCI) Model 2 on the quality and costs of care for conditions related to seven of the ten Medicare severity disease-related groups (MS-DRGs) most commonly selected by program participation. Five of these are surgical (major joint replacement of the lower extremity; double joint replacement of the lower extremity; revision of the hip or knee, hip and femur procedures except major joint; lower extremity and humerus procedure except hip, foot, and femur) and two are medical (simple pneumonia and respiratory infections; chronic obstructive pulmonary disease, bronchitis/asthma). These MS-DRGs represent two larger service lines: orthopedics and pulmonary. For each of these seven MS-DRGs, the team will first describe characteristics of provider organizations participating in bundled payment arrangements, including geographic characteristics and clinical volume. We will subsequently empirically test the effect of bundled payment arrangements on quality outcomes and costs of care for these conditions. Additionally, the team will examine any spillover effects that occur within the service lines that contain these seven MS-DRGs.

Eligibility criteria: Inclusion Criteria:

* Provider organizations that participate in model 2 of the BPCI program, accept bundled payment for the ten most common MS-DRGs, and have at least ten or greater episodes in each of the MS-DRGs.

Exclusion Criteria:

* Provider organizations who participated in the BPCI program, but do not meet inclusion criteria will be excluded.

Primary outcomes:
measure: Unplanned readmission rates
timeFrame: Up to 90 days
measure: Emergency department utilization rates for patients post-discharge
timeFrame: 12 months
measure: All-cause mortality
timeFrame: 12 months
Secondary outcomes:
measure: Total Medicare per patient per episode
timeFrame: 12 months
measure: Medicare spending per patient for the initial hospitalization
timeFrame: 12 months
Other outcomes:
Locations:
Study officials:
References: